How many employees does Atea Pharmaceuticals, Inc. have?

Atea Pharmaceuticals, Inc. reported 59 employees for the fiscal year ending Dec 2021, in the annual report it filed on February 28, 2022. That is up 51.3% from a year earlier.

What is Atea Pharmaceuticals, Inc.'s revenue per employee?

Atea Pharmaceuticals, Inc. brought in $351M of revenue in fiscal Dec 2021, which is $5.96M per employee. That ranks 1 of 109 companies we track in Biotechnology, where the median is $459K.

Where do these numbers come from?

Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Company data

Atea Pharmaceuticals, Inc. employees and revenue per employee

AVIR · Biotechnology · $412M market cap

Atea Pharmaceuticals, Inc. had 59 employees at the end of fiscal Dec 2021, up 51.3% from a year earlier. Revenue for the year was $351M, up 622.5% from a year earlier, or $5.96M per employee. Revenue and headcount both grew, and revenue grew faster.

The latest annual report we hold is more than two years old, so these numbers may be out of date.

Employees

+51.3% YoY

Revenue

$351M

+622.5% YoY

Revenue / employee

$5.96M

Peer median $459K

Rank in industry

1 of 109

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2020

Hover a year for the numbers.

AVIR employees and revenue by fiscal year
Year ending	Employees	Revenue	Per employee	Staff YoY	Revenue YoY
Dec 2021	59	$351M	$5.96M	+51.3%	+622.5%
Dec 2020	39	$48.6M	$1.25M	—	—

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years

Revenue per employee, last six fiscal years

Atea Pharmaceuticals, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

Company	Employees	Revenue	Revenue / employee	Shape
AVIR Atea Pharmaceuticals, Inc.	59	$351M	$5.96M	Efficient growth
INVA Innoviva, Inc.	159	$425M	$2.67M	Hiring ahead
RIGL Rigel Pharmaceuticals, Inc.	172	$294M	$1.71M	Efficient growth
CRMD CorMedix Inc.	191	$312M	$1.63M	Efficient growth
KRYS Krystal Biotech, Inc.	295	$389M	$1.32M	Efficient growth
ARQT Arcutis Biotherapeutics, Inc.	354	$376M	$1.06M	Efficient growth
XERS Xeris Biopharma Holdings, Inc.	435	$292M	$671K	Efficient growth
ADPT Adaptive Biotechnologies Corporation	624	$277M	$444K	Efficient growth
TWST Twist Bioscience Corporation	979	$377M	$385K	Efficient growth

Every Healthcare company

Questions about Atea Pharmaceuticals, Inc.

How many employees does Atea Pharmaceuticals, Inc. have?: Atea Pharmaceuticals, Inc. reported 59 employees for the fiscal year ending Dec 2021, in the annual report it filed on February 28, 2022. That is up 51.3% from a year earlier.
What is Atea Pharmaceuticals, Inc.'s revenue per employee?: Atea Pharmaceuticals, Inc. brought in $351M of revenue in fiscal Dec 2021, which is $5.96M per employee. That ranks 1 of 109 companies we track in Biotechnology, where the median is $459K.
Where do these numbers come from?: Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

Free game

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

More data

Compare AVIR with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Leaderboard Healthcare

Source: employee counts and revenue as stated in Atea Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed February 28, 2022. This is data, not a recommendation to buy or sell AVIR.